Primary Cutaneous CD30+/ALK- ALCL with Transition into sALCL: Favourable Response after Systemic Administration with Brentuximab Vedotin! Unique Presentation in a Bulgarian Patient!
原发性皮肤CD30+/ALK-间变性大细胞淋巴瘤(ALCL)并向散发性间变性大细胞淋巴瘤(sALCL)转化:全身应用维布妥昔单抗后疗效显著!保加利亚患者的独特病例!
期刊:Open Access Macedonian Journal of Medical Sciences
影响因子:
doi:10.3889/oamjms.2018.289
Popova, Tanya Naskova; Radinov, Atanass; Stavrov, Konstantin; Temelkova, Ivanka; Terziev, Ivan; Lozev, Ilia; Lukanova, Detelina; Mangarov, Hristo; Wollina, Uwe; Tchernev, Georgi